Study of BGB-A317 in Participants With Previously Treated Unresectable HCC

Clinical trial NCT03419897 · COMPLETED

Trial details

NCT number: NCT03419897
Sponsor: BeiGene
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma (HCC)

Start date: 2018-04-09
Primary completion: 2021-06-30
Enrollment: 249

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.